Grounded in the principles of Nature, Technology, and Innovation, Ennature Biopharma specialises in the development and production of complex phytopharmaceutical and nutraceutical actives. Our proprietary technology platforms, LIMAN™ and SCEMOD™, enable the creation of high-efficacious plant-based ingredients.

Clinically validated ingredient portfolio Maxicuma® is a clinically studied, clean label ingredient from turmeric, standardised to 40% curcuminoids and formulated with proprietary technology platform, LIMAN™ (Lecithin based Liposomal Microencapsulation). Maxicuma® helps improve joint pain, stiffness, mobility and physical performance at an ultra-low dose of 100-250mg/day. Xanthogreen® is a clean label ingredient from marigold flowers that has been clinically studied to help boost your eye health with visible effects in as little as Week 4 onwards. Formulation with proprietary technology platform, SCEMOD™ (Super Critically Enabled Molecular Optimal Dispersion) facilitates better absorption and the bio efficacy thereof.

Gingeren® is an ultra-low dose ingredient standardised to 20% total gingerols, developed using sustained release technology for enhanced half-life by 5x, along with enhanced overall tolerability. Gingeren® is clinically studied to improve the general health of menstruating women, promoting an active lifestyle.